Co-Authors
This is a "connection" page, showing publications co-authored by Alimuddin Zumla and David Hui.
Connection Strength
6.449
-
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018 08; 18(8):e217-e227.
Score: 0.764
-
Spread of MERS to South Korea and China. Lancet Respir Med. 2015 Jul; 3(7):509-10.
Score: 0.626
-
Emerging respiratory tract viral infections. Curr Opin Pulm Med. 2015 May; 21(3):284-92.
Score: 0.622
-
Middle East respiratory syndrome in the shadow of Ebola. Lancet Respir Med. 2015 Feb; 3(2):100-102.
Score: 0.609
-
Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infect Dis. 2014 Nov; 14(11):1136-1149.
Score: 0.594
-
Infection control and MERS-CoV in health-care workers. Lancet. 2014 May 31; 383(9932):1869-71.
Score: 0.582
-
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med. 2014 May; 20(3):233-41.
Score: 0.580
-
Advancing priority research on the Middle East respiratory syndrome coronavirus. J Infect Dis. 2014 Jan 15; 209(2):173-6.
Score: 0.562
-
Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome. Curr Opin Pulm Med. 2021 05 01; 27(3):146-154.
Score: 0.236
-
COVID-19 travel restrictions and the International Health Regulations - Call for an open debate on easing of travel restrictions. Int J Infect Dis. 2020 05; 94:88-90.
Score: 0.219
-
Toning down the 2019-nCoV media hype-and restoring hope. Lancet Respir Med. 2020 03; 8(3):230-231.
Score: 0.217
-
Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020 02 22; 395(10224):e35-e36.
Score: 0.216
-
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020 02; 91:264-266.
Score: 0.215
-
Vaccine against Middle East respiratory syndrome coronavirus. Lancet Infect Dis. 2019 10; 19(10):1054-1055.
Score: 0.211
-
Middle East respiratory syndrome. Lancet. 2015 Sep 05; 386(9997):995-1007.
Score: 0.156
-
Surveillance for emerging respiratory viruses. Lancet Infect Dis. 2014 Oct; 14(10):992-1000.
Score: 0.037